Status:

COMPLETED

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients

Lead Sponsor:

University of Aarhus

Conditions:

Sarcoidosis

Eligibility:

All Genders

18+ years

Brief Summary

Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficu...

Eligibility Criteria

Inclusion

  • Diagnosis of sarcoidosis
  • Signed informed consent

Exclusion

  • Inability or unwillingness to adhere to the study
  • Inability to give informed consent

Key Trial Info

Start Date :

December 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 30 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04462068

Start Date

December 1 2019

End Date

November 30 2023

Last Update

January 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aarhus University Hospital. Dep. of Respiatory Diseases and Allergology

Aarhus N, Denmark, 8200

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients | DecenTrialz